Heba A Eassa (Heba Eassa)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Molecular Docking

Tyrosine Kinase

Top Venues

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Pharmacy (Basel, Switzerland)

Current pharmaceutical design

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Maha K A Khalifa, Somaia A Abdel-Sattar, Omnya M Amin, Neveen A Kohaf, Heba S Zaky, Marwa A Abd El-Fattah, Kamilia H A Mohammed, Noha M Badawi, Ihab Mansoor, Heba A Eassa
Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2023)
Heba E Hashem, Abde El-Galil E Amr, Abdulrahman A Al-Mehizia, Ahmed M Naglah, Benson M Kariuki, Heba A Eassa, Eman S Nossier
Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies. Molecules (Basel, Switzerland) 28 (21) (2023)
Heba A Eassa
Exosomes: Double-edged Weapon in Cancer Therapy. Current pharmaceutical design (2023)
Mohamed Ismail Nounou, Heba A Eassa, Kamila Orzechowski, Hadeer A Eassa, Jerry Edouard, Nicole Stepak, Mohammad Khdeer, Mohammed Kalam, Diana Huynh, Eric Kwarteng, Kamilia H A Mohamed, Nada A Helal, Nehal A Ahmed, Ivan O Edafiogho, Ola A Ghoneim
Mobile-Based Augmented Reality Application in Pharmacy Schools Implemented in Pharmaceutical Compounding Laboratories: Students' Benefits and Reception. Pharmacy (Basel, Switzerland) 10 (4) (2022)